Article
CYP17 genotype and breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 1998
Weston A, Pan C F, Bleiweiss I J, Ksieski H B, Roy N, Maloney N, Wolff M S
Abstract excerpt
The MspAI polymorphism in the 5' untranslated region of CYP17 has been evaluated as a breast cancer risk factor in a hospital-based case-control study in New York City. The study population consisted of 363 women [123 breast cancer patients and 240 patient controls (123 benign breast disease without atypical hyperplasia, 117 women without breast disease)]. There were 224 Caucasians (76 cases, 148 controls), 55...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.